91 related articles for article (PubMed ID: 8645031)
1. [Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case].
Kudoh S; Kawamura H; Suzuki Y; Matsuzaki M; Nishina M; Tsukamoto M
Gan To Kagaku Ryoho; 1996 May; 23(6):787-90. PubMed ID: 8645031
[TBL] [Abstract][Full Text] [Related]
2. [A case of a premenopausal woman with advanced breast cancer treated with aromatization inhibition in combination with luteinizing hormone-releasing hormone agonist].
Hisamatsu K; Iwamori S; Minami K; Tanabe K; Ota K; Akiyama H
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1327-30. PubMed ID: 9279354
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
[TBL] [Abstract][Full Text] [Related]
4. Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.
Jiménez-Gordo AM; de las Heras B; Zamora P; Espinosa E; González-Barón M
Gynecol Oncol; 2000 Jan; 76(1):126-7. PubMed ID: 10620455
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
Asaga S; Ando J; Arai T; Fujii H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
[TBL] [Abstract][Full Text] [Related]
6. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
[TBL] [Abstract][Full Text] [Related]
7. [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].
Baba S; Oji Y; Teramoto M; Kawabata K; Saito A
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1905-6. PubMed ID: 19920398
[TBL] [Abstract][Full Text] [Related]
8. Use of goserelin in the treatment of breast cancer.
Rody A; Loibl S; von Minckwitz G; Kaufmann M
Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
[TBL] [Abstract][Full Text] [Related]
9. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].
Tsukagoshi S
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959
[TBL] [Abstract][Full Text] [Related]
10. [Current status of adjuvant endocrine therapy for hormone responsive breast cancer].
Ikeda T; Jinno H; Masamura S; Matsui A; Tajima G; Hohjoh T; Tokura H; Mitsui Y; Asaga S; Muto T; Fujiwara K; Kitajima M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):902-8. PubMed ID: 11478138
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics, effects, side effects of the LH-RH agonist].
Miyanaga N; Akaza H
Nihon Rinsho; 2002 Dec; 60 Suppl 11():177-81. PubMed ID: 12599567
[No Abstract] [Full Text] [Related]
12. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
13. Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.
Jonat W
Br J Cancer; 2001 Nov; 85 Suppl 2(Suppl 2):1-5. PubMed ID: 11900209
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
[TBL] [Abstract][Full Text] [Related]
15. [Endocrine therapy for advanced or recurrent breast cancer].
Sonoo H; Kurebayashi J
Gan To Kagaku Ryoho; 2001 Jul; 28(7):909-16. PubMed ID: 11478139
[TBL] [Abstract][Full Text] [Related]
16. [Sustained complete response in lung metastasis of breast cancer by goserelin--report of two cases].
Kuroi K; Tominaga T
Gan To Kagaku Ryoho; 2002 Apr; 29(4):589-94. PubMed ID: 11977544
[TBL] [Abstract][Full Text] [Related]
17. [A case of breast cancer with multiple bone metastases improved by high-dose toremifene].
Doi T; Nishiyama K; Wakasugi J; Ootaki S; Kikuchi M; Kubota K; Yamamoto H
Gan To Kagaku Ryoho; 2001 Jun; 28(6):839-43. PubMed ID: 11432355
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of pain reduction upon injecting goserelin acetate using an ice pack].
Ikeda K; Ogawa Y; Nagahara H; Xiang Z; Sakurai K; Fukuoka T; Tokunaga S; Nishiguchi Y
Gan To Kagaku Ryoho; 2010 Feb; 37(2):291-3. PubMed ID: 20154487
[TBL] [Abstract][Full Text] [Related]
19. Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P).
Berruti A; Cerutti S; Fasolis G; Sperone P; Tarabuzzi R; Bertetto O; Pagani G; Zolfanelli R; Pallotti S; Bumma C; Fontana D; Rosseti SR; Dogliotti L; Angeli A
Anticancer Res; 1997; 17(6D):4697-702. PubMed ID: 9494591
[TBL] [Abstract][Full Text] [Related]
20. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy.
McCluggage WG; Jamieson T; Dobbs SP; Grey A
Gynecol Oncol; 2006 Mar; 100(3):623-5. PubMed ID: 16246403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
